Cognition – Talk Bio

Actionable Insights Powered by AI

Cognition Therapeutics’ Stock Plummets After Alzheimer’s Drug Misses Cognitive Endpoint

9 months ago talkbio0Tagged Alzheimer 's disease, Clinical Trials, Cognition, cognitive endpoint, decline

Cognition Therapeutics, Alzheimer’s disease, cognitive endpoint, stock decline, clinical trial

Annovis Bio Reports Promising Phase III Study Results for Buntanetap in Parkinson’s Disease Treatment

10 months ago talkbio0Tagged Annovis, Bio, buntanetap, Cognition, MDS-UPDRS, Motor function (observable entity), Neurodegenerative Disorders, Parkinson 's disease, Parkinson 's Disease Rating Scale, Phase 3 Clinical Trials, Unified - Type of Agreement

Annovis Bio, Buntanetap, Parkinson’s Disease, Phase III Study, Neurodegenerative Disorders, Cognitive Function, Motor Functions, Unified Parkinson’s Disease Rating Scale (MDS-UPDRS)